Prime Movers Lab Fund I LP - Dec 1, 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role
10%+ Owner
Signature
Prime Movers Lab Fund I LP /s/ Taylor Frankel, Authorized Person
Stock symbol
VAXX
Transactions as of
Dec 1, 2022
Transactions value $
-$1,030,236
Form type
4
Date filed
12/5/2022, 04:31 PM
Previous filing
Sep 8, 2022
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A Common Stock Sale -$190K -63.8K -2.87% $2.97 2.16M Dec 1, 2022 Held by COVAXX PML SPV 1 LP F1, F2, F8
transaction VAXX Class A Common Stock Sale -$805K -271K -2.87% $2.97 9.18M Dec 1, 2022 Direct F1, F3, F8
transaction VAXX Class A Common Stock Sale -$6.73K -2.62K -0.12% $2.57 2.16M Dec 2, 2022 Held by COVAXX PML SPV 1 LP F2, F4, F8
transaction VAXX Class A Common Stock Sale -$28.6K -11.1K -0.12% $2.57 9.17M Dec 2, 2022 Direct F3, F4, F8
holding VAXX Class A Common Stock 836K Dec 1, 2022 Held by COVAXX PML SPV 2 LP F5, F8
holding VAXX Class A common stock 1.47M Dec 1, 2022 Held by COVAXX PML SPV 3 LP F6, F8
holding VAXX Class A common stock 3.62M Dec 1, 2022 Held by Prime Movers Growth Fund 1 LP F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price of $2.9717 per share represents a weighted average of purchase prices ranging from $3.38 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2 Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
F3 Held by PML. PML GP I is the general partner of PML.
F4 The price of $2.5682 per share represents a weighted average of purchase prices ranging from $2.86 to $2.40 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F5 Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F6 Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F7 Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
F8 Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.